Lunsumio
Active substance: mosunetuzumab
CONCENTRATE · MOSUNETUZUMAB 30 mg/30mL
United StatesActive
Marketing holder: Genentech, Inc.
Verified 2026-10-09 · openFDA NDC
Analogues in other countries- Source: openFDA NDC
- Countries with the substance registered: 2
Composition
- MOSUNETUZUMAB · 30 mg/30mL
Analogues by country
Products with the same active substance registered in other countries.
| Country | Products |
|---|---|
| EU 1 |
|
Import and control
Control by country
- United Statesprescription only
Source: openFDA NDC · record 01a1208c-6acb-74dd-8c55-06c5c9a48067,01a1208d-3073-71c0-8aa2-f3933f170ca0,01a12093-93bb-741a-8143-d0f636a76fec,01a12096-00dd-7c00-b85b-1747df80d905;count=4 · valid from 2026-10-09 · verified 2026-10-09
Registration
- Registration number
- 50242-142
- Registration status
- Active
- Dispensing
- Prescription only
- Route
- INTRAVENOUS
Sources
- product · openFDA NDC · 50242-142 · Verified 2026-10-09 · open in source
- registration_status · openFDA NDC · 50242-142 · Verified 2026-10-09 · open in source
- ingredients.0 · openFDA NDC · 50242-142 · Verified 2026-10-09 · open in source